NO940506L - - Google Patents

Info

Publication number
NO940506L
NO940506L NO940506A NO940506A NO940506L NO 940506 L NO940506 L NO 940506L NO 940506 A NO940506 A NO 940506A NO 940506 A NO940506 A NO 940506A NO 940506 L NO940506 L NO 940506L
Authority
NO
Norway
Prior art keywords
formula
image
radical
tetrazolyl
atherosclerosis
Prior art date
Application number
NO940506A
Other languages
English (en)
Norwegian (no)
Other versions
NO940506D0 (no
NO300810B1 (no
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO940506D0 publication Critical patent/NO940506D0/no
Publication of NO940506L publication Critical patent/NO940506L/no
Publication of NO300810B1 publication Critical patent/NO300810B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NO940506A 1993-02-15 1994-02-14 Heterocykliske, substituerte fenylcykloheksankarboksylsyrederivater, samt deres anvendelse i legemidler NO300810B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4304455A DE4304455A1 (de) 1993-02-15 1993-02-15 Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate

Publications (3)

Publication Number Publication Date
NO940506D0 NO940506D0 (no) 1994-02-14
NO940506L true NO940506L (cs) 1994-08-16
NO300810B1 NO300810B1 (no) 1997-07-28

Family

ID=6480447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940506A NO300810B1 (no) 1993-02-15 1994-02-14 Heterocykliske, substituerte fenylcykloheksankarboksylsyrederivater, samt deres anvendelse i legemidler

Country Status (25)

Country Link
US (1) US5395840A (cs)
EP (1) EP0611767B1 (cs)
JP (1) JPH06293741A (cs)
KR (1) KR940019708A (cs)
CN (1) CN1057085C (cs)
AT (1) ATE196141T1 (cs)
AU (1) AU672262B2 (cs)
CA (1) CA2115536C (cs)
CZ (1) CZ289096B6 (cs)
DE (2) DE4304455A1 (cs)
DK (1) DK0611767T3 (cs)
ES (1) ES2151908T3 (cs)
FI (1) FI106716B (cs)
GR (1) GR3034957T3 (cs)
IL (1) IL108625A (cs)
MY (1) MY131595A (cs)
NO (1) NO300810B1 (cs)
NZ (1) NZ250864A (cs)
PH (1) PH30172A (cs)
PL (1) PL177834B1 (cs)
PT (1) PT611767E (cs)
RU (1) RU2119480C1 (cs)
SK (1) SK15294A3 (cs)
UA (1) UA35574C2 (cs)
ZA (1) ZA94984B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW300219B (cs) * 1991-09-14 1997-03-11 Hoechst Ag
DE19503160A1 (de) * 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden
HRP960015B1 (en) * 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
CN1268137A (zh) 1997-07-03 2000-09-27 杜邦药品公司 治疗神经失调的咪唑并嘧啶和咪唑并吡啶
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
RU2001116581A (ru) * 1998-11-17 2004-02-20 БАСФ Акциенгезельшафт (DE) Замещенные 2-фенилбензимидазолы и 2-фенилиндолы, их получение и применение
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE10044792A1 (de) 2000-09-11 2002-04-04 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung
WO2007129707A1 (ja) 2006-05-09 2007-11-15 Mitsubishi Gas Chemical Company, Inc. ４－（４－アルキルシクロヘキシル）ベンズアルデヒド
LT3141252T (lt) 2009-06-17 2018-11-12 Vertex Pharmaceuticals Inc. Gripo virusų replikacijos inhibitoriai
EP2651940A1 (en) 2010-12-16 2013-10-23 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
AU2012272895B2 (en) 2011-06-24 2015-01-22 Amgen Inc. TRPM8 antagonists and their use in treatments
CA2839703A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
MX2014015769A (es) 2012-06-29 2015-04-10 Pfizer 7h-pirrolo[2,3-d]pirimidinas 4-(amino-substituidas)novedosas como inhibidores de lrrk2.
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
EP3578554A1 (en) 2013-11-13 2019-12-11 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
HRP20181272T1 (hr) 2013-11-13 2018-10-05 Vertex Pharmaceuticals Incorporated Postupci priprave inhibitora replikacije virusa influence
WO2015092592A1 (en) 2013-12-17 2015-06-25 Pfizer Inc. Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
EP3350178B1 (en) 2015-09-14 2021-10-20 Pfizer Inc. Novel imidazo [4,5-c]quinoline and imidazo [4,5-c][1,5]naphthyridine derivatives as lrrk2 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
ES2121773T3 (es) * 1990-06-08 1998-12-16 Hoechst Marion Roussel Inc Derivados de bencimidazol, su procedimiento de preparacion, productos intermedios, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
EP0470543A1 (de) * 1990-08-10 1992-02-12 Dr. Karl Thomae GmbH Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
DE4031635A1 (de) * 1990-10-05 1992-04-09 Thomae Gmbh Dr K Substituierte 1-benzyl-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate

Also Published As

Publication number Publication date
RU2119480C1 (ru) 1998-09-27
JPH06293741A (ja) 1994-10-21
FI940659A7 (fi) 1994-08-16
SK15294A3 (en) 1994-12-07
AU672262B2 (en) 1996-09-26
GR3034957T3 (en) 2001-02-28
ES2151908T3 (es) 2001-01-16
UA35574C2 (uk) 2001-04-16
NO940506D0 (no) 1994-02-14
PL302213A1 (en) 1994-08-22
US5395840A (en) 1995-03-07
EP0611767A1 (de) 1994-08-24
DK0611767T3 (da) 2001-01-02
KR940019708A (ko) 1994-09-14
CA2115536A1 (en) 1994-08-16
PT611767E (pt) 2001-02-28
FI106716B (fi) 2001-03-30
AU5480794A (en) 1994-08-18
NZ250864A (en) 1995-03-28
IL108625A0 (en) 1994-05-30
ZA94984B (en) 1994-08-24
ATE196141T1 (de) 2000-09-15
CN1108257A (zh) 1995-09-13
PH30172A (en) 1997-01-21
CA2115536C (en) 2004-11-02
DE59409509D1 (de) 2000-10-12
CN1057085C (zh) 2000-10-04
CZ32994A3 (en) 1994-08-17
DE4304455A1 (de) 1994-08-18
NO300810B1 (no) 1997-07-28
MY131595A (en) 2007-08-30
CZ289096B6 (cs) 2001-11-14
EP0611767B1 (de) 2000-09-06
FI940659A0 (fi) 1994-02-11
PL177834B1 (pl) 2000-01-31
IL108625A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
NO940506L (cs)
CA2131316A1 (en) A thrombin blood fraction for use in a medical procedure
CA2040865A1 (en) Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
AU3544693A (en) Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use
HU910979D0 (en) Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
DK0380331T3 (da) Anvendelse af di-tert.butylhydroxyphenylthioderivater til fremstilling af et lægemiddel til behandling eller forebyggelse af arteriosklerose eller atherosklerose
PL298890A1 (en) Sulfonylobenzyl substituted benzo- and pyridopyridones, method of obtaining sames and therapeutic agents containing them
SG86284A1 (en) Use of (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide for the manufacture of medicaments for the treatment of anxiety
HU911756D0 (en) Process for the production of medical preparations containing magnesium-pyridoxal-5'-phosphate-glutaminate, for the preventing of arterial diseases
AU639097B2 (en) Medicament for treating hyperlipidaemia and/or atherosclerosis
WO1995015161A3 (de) Arzneimittel zur behandlung der herzinsuffizienz
EP0338415A3 (en) Use of sulphonylureas in the treatment of oedema
AU2443888A (en) Agents for treating high blood pressure and cardiac insufficiency
AU2968792A (en) Method of preventing reocclusion of arteries
AU4610689A (en) Pyridine-3-peroxycarboxylic acid monopersulfate
AU655242B2 (en) Products containing verapamil and trandolapril
CA2263800A1 (en) A thrombin blood fraction for use in a medical procedure

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002